| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e4790c814adc8c5a88802341d396009 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243 |
| filingDate |
2019-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44a361fc8df68773580dd39d5898f203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60ea655881899c1cdd6a9a1ad3113db2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d065c0e2d791d52a7e4398ca9b82fb6 |
| publicationDate |
2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210054659-A |
| titleOfInvention |
Composition for enhancing the sensitivity of anti-breast cancer drug, comprising the expression inhibitor of Shwachman-Bodian-Diamond syndrome gene as an active ingredient |
| abstract |
The present invention relates to a novel composition capable of enhancing the efficiency of a breast cancer therapeutic agent, and more specifically, an anticancer agent by inhibiting the expression of the Shwachman-Bodian-Diamond Syndrome (SBDS) gene. It relates to a composition capable of enhancing the efficiency of inducing apoptosis against resistant tumors. By providing the composition for improving the efficiency of the treatment for breast cancer according to the present invention, the treatment efficiency of the anticancer agent is dramatically improved in the treatment of breast cancer in which the sensitivity to the existing anticancer agent is low or the efficacy of the anticancer agent is not well displayed. It is expected to be very useful in treating breast cancer, which is an incurable disease. |
| priorityDate |
2019-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |